These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16042700)

  • 1. Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count.
    Elliot V; Marin D; Horncastle D; Elderfield K; Apperley JF; Lampert IA; Naresh K
    Br J Haematol; 2005 Aug; 130(3):460-1. PubMed ID: 16042700
    [No Abstract]   [Full Text] [Related]  

  • 2. Total CD34+ cells per 10 HPF in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response following imatinib treatment.
    Elliot V; Marin D; Horncastle D; Elderfield K; Howard J; Apperley JF; Lampert IA; Naresh KN
    Histopathology; 2007 May; 50(6):810-2. PubMed ID: 17376172
    [No Abstract]   [Full Text] [Related]  

  • 3. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
    Ganessan K; Goel R; Kumar K; Bakhshi S
    Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
    Tondon R; Singh PA; Misra V; Singh M; Mohan S
    Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage involvement in chronic myeloid leukaemia: comparison between MBCR/ABL and mBCR/ABL cases.
    Primo D; Sanchez ML; Espinosa AB; Tabernero MD; Rasillo A; Sayagués JM; Gonzalez M; Hernandez JM; Orfao A
    Br J Haematol; 2006 Mar; 132(6):736-9. PubMed ID: 16487173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow trephine biopsy findings in chronic myeloid leukemia.
    Khonglah Y; Basu D; Dutta TK
    Malays J Pathol; 2002 Jun; 24(1):37-43. PubMed ID: 16329554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies in chronic myeloid leukemia].
    Schnabel I
    Z Gesamte Inn Med; 1989 Nov; 44(22):681-3. PubMed ID: 2483283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
    Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
    Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.
    Rao S; Sen R; Singh S; Ghalaut PS; Arora BB
    Indian J Pathol Microbiol; 2005 Jul; 48(3):341-4. PubMed ID: 16761746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of primitive stem cell antigens on the blast cells of patients with chronic myeloid leukemia].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 1996; (3):9-13. PubMed ID: 8672965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
    Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
    Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia.
    Fløisand Y; Normann AP; Heim S; Lund-Johansen F; Tjønnfjord GE
    Scand J Clin Lab Invest; 2008; 68(2):93-8. PubMed ID: 17852828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors.
    Brusa G; Zuffa E; Mancini M; Benvenuti M; Calonghi N; Barbieri E; Santucci MA
    Br J Haematol; 2006 Feb; 132(3):359-69. PubMed ID: 16409301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA1 mutational analysis in chronic myeloid leukaemia.
    Halsey C; Fisher C; Strathdee G; Gibson B; Holyoake T; Vyas P; Graham G
    Br J Haematol; 2007 May; 137(4):375-6. PubMed ID: 17408401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.